COVID-19 vector-based vaccine causing thrombosis.
Mohamed A Hendaus1,2, Fatima A Jomha3
1Department of Pediatrics, Sidra Medicine, Doha, Qatar.
Journal of Biomolecular Structure & Dynamics
|May 17, 2021
Summary
Concerns exist regarding COVID-19 vector-based vaccines and thrombosis. Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a proposed mechanism, and this commentary outlines VITT, its presentation, and treatments.
Area of Science:
- Vaccinology
- Immunology
- Hematology
Background:
- Widespread COVID-19 vaccination campaigns are underway globally.
- Concerns have arisen regarding a rare but serious side effect of vector-based COVID-19 vaccines: thrombosis.
- Vaccine-induced immune thrombotic thrombocytopenia (VITT) is the proposed mechanism linking these vaccines to thrombotic events.
Purpose of the Study:
- To provide a clear explanation of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
- To describe the clinical presentation of thrombosis following COVID-19 vaccination.
- To discuss proposed treatment strategies for VITT.
Main Methods:
- This commentary synthesizes current understanding of VITT.
- It reviews reported cases of thrombosis post-vaccination.
- It outlines diagnostic and therapeutic approaches based on emerging evidence.
Main Results:
- VITT is characterized by a specific pattern of thrombosis occurring after administration of certain COVID-19 vector-based vaccines.
- Clinical presentation includes venous and arterial thrombosis, often accompanied by thrombocytopenia.
- Early recognition and specific treatment are crucial for managing VITT.
Conclusions:
- Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a critical consideration for vector-based COVID-19 vaccines.
- Understanding VITT's mechanism, presentation, and treatment is essential for healthcare providers.
- Continued research and vigilance are necessary to ensure vaccine safety and efficacy.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
101
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
101
01:29Venous Thrombosis III: Interprofessional Care
88
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
88
02:45Blood Transfusion and Agglutination
12.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.2K
00:57Viral Recombination
24.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.2K
01:29Microorganisms in Medicine and Therapeutics
599
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
599
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K